Cocaine blocks reuptake transporters, increasing the amount of dopamine in the synapse.
Animals will lever press to receive intravenous infusions of most drugs abused by humans (esp. cocaine, amphetamine, heroin, nicotine, but not LSD, THC?)
Rats will self-administer cocaine until death (90%),
Heroin ‘less’ toxic at 36% deaths
Cocaine is rewarding at it causes an increase in dopamine levels in the brain (blocks the dopamine transporter “endocytosis”)
Rewarding effect of cocaine is blocked by: Dopamine receptor antagonists
What is the problem with dopamine receptor antagonists as a treatment for addiction?
Compliance
Several lines of evidence suggest that craving involves increased glutamate release (from prefrontal cortex to nucleus accumbens)
What are the two regions of the brain that have strong glutamate projections to the nucleus accumbens, causing craving?
The amygdala and anterior cingulate
Glutamate is involved with learned associations with the drug-taking environment
Glutamate in the nucleus accumbens triggers craving in abstinent individuals.
Future treatments may involve specific glutamate receptor antagonists or agents that normalise glutamate levels
NAC regulates glutamate levels
Acamprosate = glutamate NMDA receptor antagonist
Bupropion = dopamine reuptake inhibitor
Varenicline is a nicotine receptor partial agonist
Nicobrevin contains camphor, eucalyptus oil, Menthyl valerate, and quinine.
Clonidine
• agonist at alpha2- adrenoceptors (noradrenaline)• helps to reduce withdrawal effects of opioids, cocaine and nicotine
• noradrenaline cell bodies in the locus coeruleus are thought to produce withdrawal symptoms
• not widely used - intolerable side effects (low blood pressure, drowsy)